These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2151869)

  • 21. Processes linked to the formation of reactive oxygen species are not necessarily involved in the development of isoproterenol-induced hypertrophy of the heart. The effect of stobadine.
    Ondrejicková O; Dzurba A; Sedlák J; Tokárová J; Macicková T; Benes L
    Biomed Biochim Acta; 1991; 50(12):1251-4. PubMed ID: 1840475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Catecholamine-induced necrosis and hypertrophy. Hemodynamic factors.
    Middleton KM; Henderson AH; Lewis MJ
    Adv Myocardiol; 1985; 6():339-48. PubMed ID: 3158047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
    Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiomyopathy in a rat model of pheochromocytoma. Morphological and functional alterations.
    Rosenbaum JS; Billingham ME; Ginsburg R; Tsujimoto G; Lurie KG; Hoffman BB
    Am J Cardiovasc Pathol; 1988; 1(3):389-99. PubMed ID: 3207483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of KR-31378, a novel ATP-sensitive potassium channel activator, on hypertrophy of H9c2 cells and on cardiac dysfunction in rats with congestive heart failure.
    Hwang GS; Oh KS; Koo HN; Seo HW; You KH; Lee BH
    Eur J Pharmacol; 2006 Jul; 540(1-3):131-8. PubMed ID: 16729997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subcellular remodelling may induce cardiac dysfunction in congestive heart failure.
    Dhalla NS; Saini-Chohan HK; Rodriguez-Leyva D; Elimban V; Dent MR; Tappia PS
    Cardiovasc Res; 2009 Feb; 81(3):429-38. PubMed ID: 18852252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of cardiac hypertrophy on arterial and cardiopulmonary baroreflex control of renal sympathetic nerve activity in anaesthetized rats.
    Flanagan ET; Buckley MM; Aherne CM; Lainis F; Sattar M; Johns EJ
    Exp Physiol; 2008 Sep; 93(9):1058-64. PubMed ID: 18487313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of AT1 receptor in isoproterenol-induced cardiac hypertrophy and oxidative stress in mice.
    Zhang GX; Ohmori K; Nagai Y; Fujisawa Y; Nishiyama A; Abe Y; Kimura S
    J Mol Cell Cardiol; 2007 Apr; 42(4):804-11. PubMed ID: 17350036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of novel vasopressin receptor antagonists on renal function and cardiac hypertrophy in rats with experimental congestive heart failure.
    Bishara B; Shiekh H; Karram T; Rubinstein I; Azzam ZS; Abu-Saleh N; Nitecki S; Winaver J; Hoffman A; Abassi ZA
    J Pharmacol Exp Ther; 2008 Aug; 326(2):414-22. PubMed ID: 18467593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heart failure after long-term supravalvular aortic constriction in rats.
    Boluyt MO; Robinson KG; Meredith AL; Sen S; Lakatta EG; Crow MT; Brooks WW; Conrad CH; Bing OH
    Am J Hypertens; 2005 Feb; 18(2 Pt 1):202-12. PubMed ID: 15752948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Nigella sativa- and exercise-induced models of cardiac hypertrophy: structural and electrophysiological features.
    Al-Asoom LI; Al-Shaikh BA; Bamosa AO; El-Bahai MN
    Cardiovasc Toxicol; 2014 Sep; 14(3):208-13. PubMed ID: 24448711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterisation of a cellular model of cardiomyopathy, in the rabbit, produced by chronic administration of the anthracycline, epirubicin.
    Kelso EJ; Geraghty RF; McDermott BJ; Cameron CH; Nicholls DP; Silke B
    J Mol Cell Cardiol; 1997 Dec; 29(12):3385-97. PubMed ID: 9441844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Research on some metabolic and enzymatic modifications in experimental hypertensive myocardium.
    Balta N; Dumitriu IF; Stoian G; Filcescu V; Petec G; Dinischiotu A; Dragulescu N
    Rom J Physiol; 1995; 32(1-4):45-58. PubMed ID: 8896075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations in adult rat heart after neonatal dexamethasone therapy.
    de Vries WB; van der Leij FR; Bakker JM; Kamphuis PJ; van Oosterhout MF; Schipper ME; Smid GB; Bartelds B; van Bel F
    Pediatr Res; 2002 Dec; 52(6):900-6. PubMed ID: 12438668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrastructural aspects of contractile proteins in cardiac hypertrophy and failure.
    Ferrans VJ; Maron BJ; Jones M; Thiedemann KU
    Recent Adv Stud Cardiac Struct Metab; 1976 May 26-29; 12():129-40. PubMed ID: 145635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac hypertrophy due to physical exercise--an example of hypertrophy without decrease of contractility: unreliability of conventional estimation of contractility by simple parameters.
    Steil E; Hansis M; Hepp A; Kissling G; Jacob R
    Recent Adv Stud Cardiac Struct Metab; 1975; 5():491-6. PubMed ID: 127362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sodium-pump injury and arrhythmogenic transient depolarizations in catecholamine-induced cardiac hypertrophy.
    Mészáros J
    Eur J Pharmacol; 1992 Jan; 210(3):325-31. PubMed ID: 1319336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of myocardial cell necrosis with experimental cardiac hypertrophy.
    Revis NW; Cameron AJ
    J Pathol; 1979 Aug; 128(4):193-202. PubMed ID: 160447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in contractile and non-contractile proteins, intracellular Ca2+ and ultrastructures during the development of right ventricular hypertrophy and failure in rats.
    Morioka S; Honda M; Ishikawa S; Ishinaga Y; Yano S; Tanaka K; Moriyama K
    Jpn Circ J; 1992 May; 56(5):469-74. PubMed ID: 1534855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative histological changes in isoproterenol induced cardiac growth.
    Taylor PB; Swanson CT; Draisey TF
    Res Commun Chem Pathol Pharmacol; 1977 Jun; 17(2):341-4. PubMed ID: 141723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.